| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,358 |
5,739 |
$359K |
| 0450 |
Emergency room services |
7,116 |
6,414 |
$319K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,527 |
2,285 |
$174K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
460 |
454 |
$134K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,727 |
1,579 |
$87K |
| 70450 |
Computed tomography, head or brain; without contrast material |
644 |
620 |
$77K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,850 |
1,708 |
$73K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,786 |
2,537 |
$69K |
| 80053 |
Comprehensive metabolic panel |
5,921 |
5,406 |
$66K |
| 87631 |
|
917 |
884 |
$59K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,227 |
1,081 |
$59K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,855 |
1,606 |
$54K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,725 |
454 |
$46K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,681 |
1,539 |
$45K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
803 |
723 |
$43K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
493 |
382 |
$39K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
583 |
512 |
$36K |
| 71046 |
Radiologic examination, chest; 2 views |
1,290 |
1,266 |
$34K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,071 |
5,479 |
$34K |
| 97139 |
|
1,147 |
317 |
$34K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
450 |
425 |
$26K |
| 71045 |
Radiologic examination, chest; single view |
2,104 |
1,987 |
$25K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
266 |
243 |
$15K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
43 |
41 |
$15K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,569 |
1,486 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
942 |
935 |
$13K |
| 84484 |
|
1,844 |
1,675 |
$11K |
| 83690 |
|
2,167 |
1,986 |
$11K |
| 0760 |
|
247 |
231 |
$10K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,521 |
1,318 |
$10K |
| 80061 |
Lipid panel |
851 |
847 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,462 |
1,388 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
632 |
556 |
$8K |
| J3490 |
Unclassified drugs |
359 |
212 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
155 |
151 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
131 |
106 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
657 |
656 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
184 |
139 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
204 |
204 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
351 |
300 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,420 |
1,341 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,492 |
1,355 |
$4K |
| 84703 |
|
723 |
688 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
69 |
63 |
$4K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
77 |
74 |
$4K |
| 85027 |
|
695 |
663 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
375 |
354 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
70 |
68 |
$2K |
| 81015 |
|
917 |
885 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
166 |
135 |
$2K |
| Z7502 |
|
43 |
43 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
241 |
203 |
$2K |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
1,287 |
1,259 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
14 |
14 |
$2K |
| 85610 |
|
686 |
659 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
24 |
24 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
16 |
12 |
$1K |
| 90715 |
|
36 |
36 |
$1K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
12 |
12 |
$1K |
| 87077 |
|
224 |
217 |
$1K |
| 73030 |
|
39 |
37 |
$914.36 |
| 87186 |
|
165 |
160 |
$882.05 |
| 85730 |
|
251 |
245 |
$868.60 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
107 |
99 |
$821.00 |
| 87430 |
|
102 |
98 |
$808.20 |
| 73630 |
|
26 |
24 |
$724.55 |
| 73610 |
|
24 |
24 |
$678.12 |
| 83605 |
|
88 |
78 |
$674.89 |
| 73562 |
|
15 |
15 |
$450.77 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
14 |
$426.02 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$424.62 |
| 87040 |
|
43 |
39 |
$410.19 |
| 73130 |
|
15 |
13 |
$409.61 |
| 81001 |
|
187 |
182 |
$396.41 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
55 |
54 |
$391.70 |
| 72100 |
|
12 |
12 |
$391.41 |
| 85379 |
|
71 |
69 |
$386.57 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
25 |
25 |
$321.00 |
| A4649 |
Surgical supply; miscellaneous |
3,496 |
1,991 |
$203.26 |
| 86803 |
|
12 |
12 |
$147.24 |
| 86780 |
|
13 |
13 |
$144.69 |
| J2060 |
Injection, lorazepam, 2 mg |
26 |
24 |
$139.44 |
| 82150 |
|
27 |
27 |
$124.38 |
| 83880 |
|
12 |
12 |
$117.72 |
| 85014 |
|
106 |
101 |
$117.25 |
| 85018 |
|
106 |
101 |
$116.08 |
| 83735 |
|
28 |
24 |
$108.80 |
| 86701 |
|
14 |
14 |
$108.08 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
14 |
14 |
$102.23 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
16 |
12 |
$99.74 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
26 |
24 |
$93.76 |
| 82948 |
|
27 |
25 |
$73.20 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
13 |
12 |
$63.84 |
| 88142 |
|
12 |
12 |
$53.64 |
| 81003 |
|
13 |
13 |
$17.28 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
68 |
53 |
$13.41 |
| 0259 |
|
227 |
161 |
$8.98 |
| 0637 |
|
46 |
42 |
$7.23 |
| 0270 |
|
81 |
72 |
$2.61 |
| 0250 |
|
12 |
12 |
$0.00 |